
Murli Biotech Private Limited
Founded in 2007 and headquartered in Maharashtra, India.
Founded in 2007 and headquartered in Maharashtra, India.
Thane, Maharashtra, India
+91-XXXXXXXXXX
U24119MH2007PTC171596
171596
Private Limited Indian Non-Government Company
13 Jun 2007
28 Sep 2013
31 Mar 2013
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Dinesh Chavan ![]() | Director | 13-Jun-2007 | Current |
Atmasmruti Chavan ![]() | Director | 13-Jun-2007 | Current |
Enhance accessibility to Murli Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Murli Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Dinesh Chavan and Atmasmruti Chavan are mutual person
Dinesh Chavan and Atmasmruti Chavan are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Murli Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Murli Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Murli Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Murli Biotech Private Limited last Annual general meeting of members was held on 28 Sep 2013 as per latest MCA records.
Murli Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Mumbai.
Dinesh Nilkantharao Chavan was appointed as a Director was appointed as a Director on 13 Jun 2007 & has been associated with this company since 17 years 9 months .
Atmasmruti Dinesh Chavan was appointed as a Director was appointed as a Director on 13 Jun 2007 & has been associated with this company since 17 years 9 months .
Murli Biotech Private Limited was registered on 13 Jun 2007 with Roc Mumbai & aged 17 years 9 months as per MCA records.
Murli Biotech Private Limited was incorporated on 13 Jun 2007.
The authorized share capital of Murli Biotech Private Limited is ₹ 3.00 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Murli Biotech Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Murli Biotech Private Limited is 47 2Nd Floor Asiatic Arcade Vartak Nagar Pokhran Road No.1, India, Thane, Maharashtra, 400606.
The corporate identification number (CIN) of Murli Biotech Private Limited is U24119MH2007PTC171596 and the company number is 171596 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Murli Biotech Private Limited was filed with the ROC on 31 Mar 2013.
Search company & director profiles for free and gain access to critical business data.